This insulin-dependent T2D stage is refractory to treatment, with a need for exogenous insulin coupled to insulin resistance, leading to high rates of secondary pathologies, such as diabetic foot or diabetic retinopathy. This evidence concerns the gene INS and diabetic retinopathy.